Focus
Hodgkin’s Lymphoma
New Immunotherapy Boosts Hodgkin Lymphoma Survival Rate to 92 Percent
The treatment also showed a reduction in long-term side effects.
|
New Immunotherapy Boosts Hodgkin Lymphoma Survival Rate to 92 Percent
The treatment also showed a reduction in long-term side effects.
|